Chemotherapy: Current drugs still have potential in advanced ovarian cancer

Autor:	Thomas, Hogberg
Rok vydání:	2010
Předmět:	Ovarian Neoplasms Sweden Antibiotics Antineoplastic Paclitaxel Antineoplastic Agents Antineoplastic Agents Phytogenic Carboplatin Doxorubicin Area Under Curve Confidence Intervals Disease Progression Humans Female Cisplatin
Zdroj:	Nature reviews. Clinical oncology. 7(4)
ISSN:	1759-4782
Popis:	Dose-dense administration of paclitaxel as well as intraperitoneal administration of platinum and paclitaxel as first-line treatments provide similar advantages compared with standard treatment in advanced ovarian cancer. Both approaches, however, need to be confirmed by additional studies. a low dose of pegylated liposomal doxorubicin combined with carboplatin is superior to standard paclitaxel and carboplatin in relapsed platinum-sensitive ovarian cancer.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=pmid________::ac94bca6e06a48d6e4df9596f999fe7f https://pubmed.ncbi.nlm.nih.gov/20354543 Zobrazit plný text záznamu